Morningstar

Rydex Biotechnology Fund Class A RYBOX

Morningstar Medalist Rating
Medalist Rating as of | See Rydex Investment Hub
  • NAV / 1-Day Return 76.72  /  +0.07 %
  • Total Assets 130.1M
  • Adj. Expense Ratio
    1.630%
  • Expense Ratio 1.630%
  • Distribution Fee Level High
  • Share Class Type Front Load
  • Category Health
  • Investment Style Mid Blend
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 0.00
  • Turnover 75%

USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:11 AM GMT+0

Morningstar’s Analysis RYBOX

Will RYBOX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable RYBOX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the RYBOX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of RYBOX’s parent organization’s priorities and whether they’re in line with investors’ interests.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Rydex Biotechnology A holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

by Morningstar Automated Analysis
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RYBOX

More RYBOX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 38.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

AbbVie Inc

8.47 11M
Healthcare

Amgen Inc

5.58 7M
Healthcare

Gilead Sciences Inc

4.81 6M
Healthcare

Vertex Pharmaceuticals Inc

4.31 5M
Healthcare

Regeneron Pharmaceuticals Inc

3.73 5M
Healthcare

Revolution Medicines Inc Ordinary Shares

2.58 3M
Healthcare

BeOne Medicines Ltd ADR

2.50 3M
Healthcare

Illumina Inc

2.35 3M
Healthcare

Royalty Pharma PLC Class A

2.18 3M
Healthcare

Natera Inc

2.17 3M
Healthcare

Sponsor Center